Tyde Wellness Review
Best for: Cash-pay patients wanting transparent compounded-GLP-1 pricing with named, LegitScript-certified pharmacy fulfillment and the option to bundle menopause/HRT, hair loss, or longevity peptides through a single 50-state provider.
Tyde Wellness (tydewellness.com) is a 50-state compounded-GLP-1 and longevity telehealth platform operated by Tyde Medical Center LLC (clinical services) and Tyde Wellness LLC (administrative). Compounded semaglutide starts at $149/month and compounded tirzepatide at $249/month, with microdose and full-strength options; low-dose naltrexone (oral) starts at $119-$129/month. Free consultation; subscription with cancel-anytime. Five named LegitScript-certified 503A compounding pharmacy partners disclosed: Belmar Pharma Solutions (CO), Casa Pharma (TX), Olympia Pharmacy (FL), Red Rock Home Pharmacy (UT), and Beaker Pharmacy (TX). Multi-vertical: weight loss, menopause/HRT (estradiol, progesterone), hair loss, and longevity peptides (sermorelin, NAD+, GHK-Cu, B12). Live-verified 2026-05-15: LegitScript-approved badge and HIPAA-compliant.
High confidence · Last verified 2026-05-15 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Tyde Wellness is one of the most affordable GLP-1 options on the market.
Score Breakdown
Drugs Offered
Tyde Wellness prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| All doses (microdose + full-strength) | compounded | $149 |
| All doses (microdose + full-strength) | compounded | $249 |
| Oral tablet (low-dose) | compounded | $119 |
✓ Pros
- •All 50 states served (verbatim list disclosed on /states-we-serve)
- •Pricing publicly transparent: semaglutide from $149/mo, tirzepatide from $249/mo
- •LegitScript-certified with badge linking to verification
- •Five named LegitScript-certified 503A pharmacy partners disclosed with verbatim addresses (Belmar CO, Casa TX, Olympia FL, Red Rock UT, Beaker TX)
- •Free consultation; cancel-anytime subscription with no long-term commitment
- •Microdose and full-strength options for both GLP-1s
- •Multi-vertical platform — single account covers weight loss, HRT, hair, longevity peptides
✗ Cons
- •Compounded semaglutide and tirzepatide are NOT FDA-approved finished drug products
- •Brand-name GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic) not offered
- •Tirzepatide pricing higher than several competitors offering $200-$249/mo bundles
- •Corporate address and named medical director not publicly disclosed
- •No NABP .pharmacy seal visible
Ready to start with Tyde Wellness?
Starting at $119/month. See current pricing and start your free consultation.
Sources & methodology
Our Tyde Wellness review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Tyde Wellness
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Tyde Wellness?
Starting at $119/month. See current pricing and start your free consultation.